June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Clinical Manifestation and Effect of Ganciclovir Therapy for Cytomegalovirus Corneal Endotheliitis
Author Affiliations & Notes
  • Tsutomu Inatomi
    Ophthalmology, Kyoto Prefectural Univ of Med, Kamigyo-Ku, Japan
  • Noriko Koizumi
    Biomedical Engineering Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan
  • Yuichi Ohashi
    Ophthalmology, Ehime University School of Medicine, Ehime, Japan
  • Yoshitsugu Inoue
    Ophthalmology, Tottori University, Faculty of Medicine, Tottori, Japan
  • Manabu Mochizuki
    Ophthalmology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
  • Kohji Nishida
    Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Footnotes
    Commercial Relationships Tsutomu Inatomi, None; Noriko Koizumi, None; Yuichi Ohashi, None; Yoshitsugu Inoue, None; Manabu Mochizuki, Santen (F), Senju (F), Ohtsuka (F), Daiichi-Sankyo (F), Mitsubishi-Tanabe (F), AMO Japan (F), Alcon Japan (F); Kohji Nishida, Alcon (C), Alcon (F), HOYA (F), Senju (F), Pfizer (F), Santen (F), Osaka University (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1683. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tsutomu Inatomi, Noriko Koizumi, Yuichi Ohashi, Yoshitsugu Inoue, Manabu Mochizuki, Kohji Nishida, Idiopathic Corneal Endotheliitis Study Group; Clinical Manifestation and Effect of Ganciclovir Therapy for Cytomegalovirus Corneal Endotheliitis. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1683.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To report the findings of an epidemiological survey conducted in Japan regarding the clinical manifestations and the effect of ganciclovir antiviral therapy for the treatment of patients with cytomegalovirus (CMV) corneal endotheliitis.

Methods: An epidemiological survey was conducted in Japan and the clinical manifestations of 109 eyes of 106 cases diagnosed as CMV corneal endotheliitis were analyzed retrospectively. Prospective, multicenter clinical treatment was performed for 7 eyes of 7 cases. The mean patient age was 67.4±10.4 years, and the mean follow-up period was 12 months. The combined therapy of systemic ganciclovir (5mg/kg, 2 times daily) with topical 0.5% ganciclovir instillation was applied for 2 weeks following the tapering of topical instillation. Clinical evaluation was performed by use of real-time polymerase chain reaction (PCR) and slit-lamp examination.

Results: Of the total 106 cases, 85 cases (80.2%) were male and 21 cases (19.8%) were female. Coin-shaped lesions and linear keratic precipitates (KPs) were observed in 70.6% and 8.3% of the cases, respectively. Clinical manifestations included corneal edema (73.4%), endothelial loss (81.7%), iritis (67.9%), and elevation of intraocular pressure (66.1%). In the prospective study, the average CMV viral load in aqueous humor before treatment was 8.55x104 copies/ml (range: 8.3x102 - 1.55x105 copies/ml). Coin-shaped lesions or linear KPs were detected in 100% and 29% of the cases, respectively, and 85.7% of the cases showed sustained virologic response after the initial combined therapy. All cases showed negative by PCR with additional topical ganciclovir therapy, but 3 cases (42.8%) showed the elevation of intraocular pression and 1 case (14.5%) showed the recurrence. Mean endothelial cell density (CED) (cell/mm2 ) at before and 1-month post treatment was 1160±365 and 1048±440, respectively. No significant reduction of CED and no adverse effects were observed.

Conclusions: Corneal endotheliitis with coin-shaped lesions or linear KPs, similar to the clinical rejection line, are major clinical manifestations in CMV corneal endotheliitis. The combined therapy of systemic and topical ganciclovir instillation is safe and effective for the treatment of patients with CMV corneal endotheliitis.

Keywords: 479 cornea: clinical science • 481 cornea: endothelium • 492 cytomegalovirus  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.